Clinical Study of Coronary Extension Catheter

Recruiting N/A Interventional Study
Coronary Artery Disease (CAD) Percutaneous Coronary Intervention (PCI)
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
69 (estimated)
Sponsor
BrosMed Medical Co., Ltd · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This prospective, multicenter, single-arm study plans to enroll 69 subjects. Subjects meeting the protocol criteria will receive treatment with coronary extension catheters. The safety and efficacy of these catheters in percutaneous coronary intervention will be assessed through the collection and analysis of efficacy and safety endpoints during treatment and follow-up.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age ≥18 years, regardless of gender; * Patients suitable for percutaneous coronary intervention (PCI) and for whom the use of an extension catheter is planned to assist the intervention; * Ability to understand the purpose of the study, willingness to voluntarily participate, …
Contacts

Sone, PhD

010-63198850

songxiantao0929@qq.com

CONTACT